Refractory Epilepsy Clinical Trial
Official title:
Phase 2/3 Study of the Modified Atkins Diet in Young Children With Refractory Epilepsy
Verified date | January 2019 |
Source | Lady Hardinge Medical College |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The modified Atkins diet is a non-pharmacologic therapy for intractable childhood epilepsy that was designed to be a less restrictive alternative to the traditional ketogenic diet. This diet is started on an outpatient basis without a fast, allows unlimited protein and fat, and does not restrict calories or fluids. Modified Atkins diet is of special importance in resource constraint settings with paucity of trained dieticians. However, there is paucity published data on the use of the modified Atkins diet in refractory epilepsy in young children. This study aims to evaluate the efficacy and tolerability of the modified Atkins diet in refractory epilepsy in young children.
Status | Completed |
Enrollment | 31 |
Est. completion date | March 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Months to 3 Years |
Eligibility |
Inclusion Criteria: 1. Age: 9 months to 3 years. 2. Seizures persisting at least three per week for > 1 month despite the appropriate use of at least 2 Anti-epileptic drugs. Exclusion Criteria: 1. Known or suspected inborn error of metabolism, as evidenced by: Clinical suspicion of metabolic disorder as evidenced by 2 or more of the following- a history of parental consanguinity, prior affected siblings, unexplained vomiting, intermittent worsening of symptoms, recurrent episodes of lethargy, altered sensorium, or ataxia, hepatosplenomegaly on examination And/ or 2 or more of the following biochemical abnormalities High blood ammonia (>80mmol/L), High arterial lactate (>2 mmol/L), metabolic acidosis (pH <7.2), hypoglycaemia (blood sugar <40 mg/dl), abnormal urinary aminoacidogram, presence of reducing sugars or ketones in urine, and positive results on urine neurometabolic screening tests. 2. Motivational or psychosocial issues in the family which would preclude compliance 3. Systemic illness- chronic hepatic, cardiac, renal or pulmonary disease 4. Severe acute malnutrition. |
Country | Name | City | State |
---|---|---|---|
India | Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital | New Delhi | Delhi |
Lead Sponsor | Collaborator |
---|---|
Lady Hardinge Medical College |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Proportion of children with seizure freedom at 3 months | 3 months | ||
Other | Percentage of children discontinuing diet before 3 months as per parenteral reports | 3 months | ||
Primary | Proportion of children with > 50% seizure reduction at 3 months | After 3 months of diet initiation | ||
Secondary | Frequency of adverse effects of the modified Atkins diet. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02866240 -
Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy
|
N/A | |
Withdrawn |
NCT04753983 -
A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy
|
N/A | |
Completed |
NCT01899898 -
Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
|
Phase 2/Phase 3 | |
Recruiting |
NCT05493722 -
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
|
Early Phase 1 | |
Recruiting |
NCT03062514 -
Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy
|
N/A | |
Recruiting |
NCT04770337 -
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
|
N/A | |
Recruiting |
NCT05232630 -
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
|
Phase 4 | |
Completed |
NCT04545346 -
The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy
|
N/A | |
Not yet recruiting |
NCT04542629 -
Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
|
Phase 4 | |
Terminated |
NCT03570489 -
Randomized Controlled Trial on Cardiovascular Exercise in Uncontrolled Epilepsy:
|
N/A | |
Completed |
NCT05031208 -
Acute and Long Term Effects of VNS on Memory in Patients With Refractory Epilepsy
|
N/A | |
Completed |
NCT03676569 -
Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy
|
Phase 1 | |
Withdrawn |
NCT03115489 -
Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus
|
Phase 2/Phase 3 | |
Completed |
NCT02876289 -
Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon)
|
N/A | |
Completed |
NCT01521754 -
Product Surveillance Registry- Deep Brain Stimulation for Epilepsy
|
||
Recruiting |
NCT04684797 -
Localization of the Reward Positivity to ACC
|
N/A | |
Completed |
NCT05292183 -
Modulation of Emotion Perception in Humans Via Amygdala Stimulation
|
N/A | |
Terminated |
NCT04398667 -
European Non-interventional Study on Refractory Epilepsy With Developmental Delay
|
||
Active, not recruiting |
NCT04218812 -
Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation
|
N/A | |
Terminated |
NCT02474407 -
Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)
|
Phase 2 |